Legend Biotech Ownership | Who Owns Legend Biotech?
Legend Biotech Ownership Summary
Legend Biotech is owned by 31.38% institutional investors, 1.30% insiders, and 67.32% retail investors. Fmr is the largest institutional shareholder, holding 30.09% of LEGN shares. Fidelity OTC is the top mutual fund, with 2.54% of its assets in Legend Biotech shares.
LEGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Legend Biotech | 31.38% | 1.30% | 67.32% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 27.70M | 30.09% | $903.39M |
| Westfield capital management co lp | 6.16M | 6.83% | $134.02M |
| Hhlr advisors | 5.98M | 6.50% | $195.16M |
| Blackrock funding, inc. /de | 4.28M | 4.74% | $92.98M |
| Suvretta capital management | 3.82M | 4.15% | $124.51M |
| Deerfield management company, l.p. (series c) | 2.96M | 3.22% | $96.60M |
| Blackrock | 5.72M | 3.14% | $253.40M |
| Artisan partners limited partnership | 2.55M | 2.77% | $83.09M |
| Goldman sachs group | 2.17M | 2.41% | $47.27M |
| Braidwell lp | 1.83M | 1.98% | $59.55M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ivyrock asset management (hk) | 804.00K | 9.22% | $17.48M |
| Matthews capital management | 956.82K | 6.31% | $20.80M |
| Hhlr advisors | 5.98M | 4.77% | $195.16M |
| Johnson & johnson | 814.59K | 3.19% | $17.71M |
| Suvretta capital management | 3.82M | 3.19% | $124.51M |
| Eagle health investments lp | 408.65K | 1.95% | $8.88M |
| Allostery investments lp | 4.00K | 1.81% | $141.96K |
| Braidwell lp | 1.83M | 1.77% | $59.55M |
| Great point partners | 113.46K | 1.53% | $3.70M |
| Deerfield management company, l.p. (series c) | 2.96M | 1.47% | $96.60M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 27.70M | 0.05% | 2.03M |
| Goldman sachs group | 2.17M | 0.01% | 1.12M |
| Balyasny asset management | 947.63K | 0.05% | 746.64K |
| Jpmorgan chase | 945.69K | 0.00% | 636.09K |
| Acadian asset management | 582.15K | 0.02% | 582.15K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -7.51M |
| Capital world investors | - | - | -2.39M |
| Wellington management group llp | - | - | -1.86M |
| Paradigm biocapital advisors lp | - | - | -1.20M |
| Federated hermes | 16.50K | 0.00% | -1.05M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Acadian asset management | 582.15K | 0.02% | 582.15K | $12.65M |
| Eagle health investments lp | 408.65K | 1.95% | 408.65K | $8.88M |
| Rakuten investment management | 232.47K | 0.02% | 232.47K | $6.60M |
| Panagora asset management | 139.89K | 0.01% | 139.89K | $3.04M |
| Verition fund management | 54.27K | 0.00% | 54.27K | $1.18M |
Sold Out
| Holder | Change |
|---|---|
| Larson financial group | -2.00 |
| Abound wealth management | -4.00 |
| Cva family office | -15.00 |
| Smartleaf asset management | -21.00 |
| Bryn mawr trust | -27.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 139 | -35.65% | 28,301,091 | -66.19% | 31 | 0.38% | 66 | -40.00% | 41 | -28.07% |
| Sep 30, 2025 | 208 | -7.56% | 83,554,687 | -1.27% | 90 | 4.30% | 104 | -4.59% | 57 | -32.94% |
| Jun 30, 2025 | 224 | 2.75% | 84,632,757 | -1.43% | 45 | 2.11% | 108 | 5.88% | 85 | 10.39% |
| Mar 31, 2025 | 221 | -1.78% | 86,577,050 | -12.78% | 47 | 1.59% | 104 | -20.00% | 78 | 39.29% |
| Dec 31, 2024 | 138 | -36.41% | 51,770,843 | -43.26% | 28 | 1.14% | 79 | -31.90% | 38 | -39.68% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity OTC | 4.68M | 2.54% | - |
| Fidelity Select Health Care | 2.85M | 1.54% | - |
| Invesco Emerging Markets Equity | 2.69M | 1.46% | -277.61K |
| Invesco Developing Markets A | 2.69M | 1.46% | - |
| Fidelity Growth Compy Commingled Pl O | 2.43M | 1.32% | - |
| T. Rowe Price US Growth Stock Composite | 2.32M | 1.26% | -77.22K |
| T. Rowe Price Growth Stock | 2.27M | 1.24% | -32.51K |
| Fidelity VIP Contrafund Initial | 2.14M | 1.16% | -50.40K |
| Jupiter Merian Glb Eq AbsRet I USD Acc | 2.09M | 1.13% | 2.09M |
| MFS Mid Cap Growth Equity | 1.56M | 0.85% | -17.03K |
LEGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools